Warning issued over adrenaline pen fault Allergy patients are being warned of a potential fault with Emerade adrenaline pens.
The Medicines and Healthcare products Regulatory Agency (MHRA) said some have blocked needles, so cannot deliver adrenaline.
Around two in every 1,000 pens are thought to be affected. BBC News
See also:
The Medicines and Healthcare products Regulatory Agency (MHRA) said some have blocked needles, so cannot deliver adrenaline.
Around two in every 1,000 pens are thought to be affected. BBC News
See also:
- Class 4 Medicines Defect Information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 55-06/18) Medicines and Healthcare products Regulatory Agency
No comments:
Post a Comment